Alendronate sodium and Dipyrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alendronate sodium (alendronate sodium) and Dipyrone (metamizole). Common drug interactions include pneumonia among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Alendronate sodium and Dipyrone. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.

What is Dipyrone?

Dipyrone has active ingredients of metamizole. eHealthMe is studying from 1,876 Dipyrone users. Check the latest studies of Dipyrone.

On Jul, 08, 2026

11 people who take Alendronate sodium and Dipyrone together, and have interactions are studied.

Alendronate sodium and Dipyrone drug interactions.

What are the common drug interactions of Alendronate Sodium and Dipyrone, by gender? *:

female:

Pneumonia
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fall
General physical health deterioration (weak health status)
Lung adenocarcinoma stage ii (the cancer has spread to some lymph nodes near the original tumour)
Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
Pneumonia escherichia (pneumonia due to bacteria escherichia coli)
Pruritus (severe itching of the skin)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

male:

Hypertension (high blood pressure)
Acute respiratory distress syndrome
Cardiac valve disease (heart valve disease)
Cataract (clouding of the lens inside the eye)
Chest discomfort
Colonoscopy
Conjunctivitis (pink eye)
Dyspnoea (difficult or laboured respiration)
Dysstasia (difficulty in standing)
Fall

What are the common drug interactions of Alendronate Sodium and Dipyrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia postoperative
Arthralgia (joint pain)
Atypical femur fracture
Back pain
Blood alkaline phosphatase decreased
Blood cholesterol increased
Bone disorder
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cardiac valve disease (heart valve disease)
Cataract (clouding of the lens inside the eye)

60+:

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Pruritus (severe itching of the skin)
Acute respiratory distress syndrome
Chest discomfort
Conjunctivitis (pink eye)
Drug effect decreased
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)
Gangrene (body tissue dies)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 81.82%
Pain: 3 people, 27.27%
Gastric Disorder (disease of stomach): 2 people, 18.18%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 1 person, 9.09%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 9.09%
Headache (pain in head): 1 person, 9.09%
Diabetes: 1 person, 9.09%
Depression: 1 person, 9.09%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 9.09%
Calcium Metabolism Disorder (occur when the body has too little or too much calcium): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Alendronate sodium and Dipyrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously